BSE Live
Sep 05, 16:01Prev. Close
3325.75
Open Price
3318.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:51Prev. Close
3319.40
Open Price
3309.00
Bid Price (Qty.)
3249.60 (7)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 83.59 | 83.48 | 83.37 | 83.35 | 83.35 | |
Total Share Capital | 83.59 | 83.48 | 83.37 | 83.48 | 83.46 | |
Reserves and Surplus | 2,089.12 | 1,714.66 | 1,524.67 | 1,366.45 | 1,121.91 | |
Total Reserves and Surplus | 2,089.12 | 1,714.66 | 1,524.67 | 1,366.45 | 1,121.91 | |
Total Shareholders Funds | 2,172.72 | 1,849.28 | 1,666.30 | 1,508.21 | 1,245.18 | |
Minority Interest | 33.76 | 36.08 | 33.25 | 35.46 | 30.96 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 83.33 | 166.67 | 0.00 | |
Deferred Tax Liabilities [Net] | 3.37 | 2.39 | 2.94 | 4.04 | 0.76 | |
Other Long Term Liabilities | 102.64 | 103.02 | 129.99 | 138.86 | 110.16 | |
Long Term Provisions | 1.95 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 107.96 | 105.41 | 216.26 | 309.57 | 110.91 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 83.33 | 153.34 | 178.85 | 0.00 | |
Trade Payables | 198.85 | 186.57 | 156.10 | 147.38 | 144.13 | |
Other Current Liabilities | 168.36 | 157.42 | 131.18 | 146.70 | 112.94 | |
Short Term Provisions | 35.15 | 37.87 | 29.14 | 27.05 | 17.22 | |
Total Current Liabilities | 402.35 | 465.19 | 469.75 | 499.99 | 274.29 | |
Total Capital And Liabilities | 2,716.79 | 2,455.96 | 2,385.56 | 2,353.22 | 1,661.33 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 369.16 | 376.73 | 401.00 | 415.37 | 305.87 | |
Intangible Assets | 251.07 | 302.61 | 356.22 | 410.00 | 56.03 | |
Capital Work-In-Progress | 3.48 | 3.95 | 2.97 | 14.45 | 6.13 | |
Fixed Assets | 623.71 | 684.99 | 762.16 | 840.38 | 371.51 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 86.62 | 44.86 | 40.42 | 37.04 | 28.02 | |
Long Term Loans And Advances | 0.00 | 0.03 | 0.06 | 0.11 | 0.07 | |
Other Non-Current Assets | 94.84 | 51.20 | 62.00 | 50.64 | 31.19 | |
Total Non-Current Assets | 1,353.28 | 1,329.27 | 1,412.48 | 1,478.07 | 516.16 | |
CURRENT ASSETS | ||||||
Current Investments | 326.70 | 113.78 | 149.94 | 65.46 | 59.30 | |
Inventories | 36.13 | 37.31 | 33.81 | 52.54 | 42.56 | |
Trade Receivables | 88.12 | 77.40 | 70.82 | 85.40 | 66.70 | |
Cash And Cash Equivalents | 838.68 | 830.31 | 665.41 | 617.59 | 926.03 | |
Short Term Loans And Advances | 1.12 | 1.28 | 1.36 | 1.07 | 0.93 | |
OtherCurrentAssets | 72.76 | 66.63 | 51.74 | 53.10 | 49.65 | |
Total Current Assets | 1,363.51 | 1,126.70 | 973.09 | 875.15 | 1,145.17 | |
Total Assets | 2,716.79 | 2,455.96 | 2,385.56 | 2,353.22 | 1,661.33 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 21.37 | 20.29 | 18.28 | 25.99 | 20.10 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 65.46 | 59.30 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak